GeminIQ Website Logo

Viewing ALKS free

Subscribe for full history, 90+ metrics, screener, watchlist...

Alkermes plc.

ALKS

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
512352389616521400291396535421457648
Restricted Cash Current
00731---------
Available For Sale Securities Debt Securities Curr…
145160200495495484461513341324316241
Receivables Net Current
456408334354355319385367366316332338
Inventory Net
299337197191192183183191195198186192
Prepaid Expense And Other Assets Current
1111027984719091941011129843
Assets Held For Sale Not Part Of Disposal Group Cu…
---------9794-
Contract With Customer Asset Net Current
--0113533113
Assets Current
1,5231,3591,9291,7421,6351,4791,4151,5641,5421,4691,4861,465
Property Plant And Equipment Net
218221222247239234228225223225227328
Long Term Investments
352602838327319866340106
Operating Lease Right Of Use Asset
7678777981828486889091103
Intangible Assets Net Including Goodwill
--84848484848484-85-
Intangible Assets Net Excluding Goodwill
1,7611,784----------
Goodwill
594596-------838393
Finite Lived Intangible Assets Net
---------1211
Deferred Income Tax Assets Net
123135126130156152155160167183196162
Other Assets Noncurrent
625949202018171716121211
Assets
4,3934,2582,4872,3302,2532,0822,0562,1552,2072,1242,1362,279
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
332293290215246186185160240206241243
Operating Lease Liability Current
7877666666615
Contract With Customer Liability Current
--0012123333
Long Term Debt Current
2727-----33333
Liabilities Of Disposal Group Including Discontinu…
----------5-
Liabilities Current
662599543474506444465454516459520503
Operating Lease Liability Noncurrent
626463656668697173747679
Business Combination Contingent Consideration Liab…
136109----------
Long Term Debt Noncurrent
1,4771,484-----286286287288288
Deferred Income Tax Liabilities Net
180182----------
Other Liabilities Noncurrent
686861575659565348495054
Liabilities
2,5852,507668596628570591863923869934924
Stockholders Equity
Common Stock Value
222222222222
Treasury Stock Common Value
-503-501-450-450-450-448-419-419-303-218-189-187
Additional Paid In Capital Common Stock
3,1133,0553,0052,9672,9412,9132,8612,8322,8042,7812,7373,003
Accumulated Other Comprehensive Income Loss Net Of…
-3-3-2-1-1-1-20-4-4-3-6
Retained Earnings Accumulated Deficit
-801-801-735-784-867-954-976-1,123-1,215-1,307-1,344-1,456
Stockholders Equity
1,8091,7521,8191,7331,6251,5121,4651,2921,2841,2551,2031,356
Liabilities And Stockholders Equity
4,3934,2582,4872,3302,2532,0822,0562,1552,2072,1242,1362,279
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
505050505050505050505050
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
450450450450450450450450450450450450
Common Stock Shares Issued
185184181180180180177176176176173172
Shares Outstanding
168166166165165165162162166169167167
Treasury Stock Common Shares
171715151515141410766

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202616.39%51.94%45.90%---------
2025-4.02%-4.87%-4.45%10.19%2.93%12.07%-7.71%-8.23%2.03%-9.31%11.24%20.75%
20240.04%3.92%3.42%2.79%4.34%9.05%4.99%13.63%4.58%2.54%-10.27%-5.13%
2023------3.37%16.93%20.26%-1.47%-16.31%-17.58%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.30
2.27
3.55
3.67
3.23
3.33
3.04
3.45
2.99
3.20
2.86
2.91
Quick Ratio
1.68
1.53
3.04
3.09
2.71
2.72
2.45
2.82
2.42
2.53
2.31
2.44
Working Capital
860.82M
759.15M
1.39B
1.27B
1.13B
1.04B
950.16M
1.11B
1.03B
1.01B
965.29M
961.67M
Leverage & Debt
Debt to Equity
1.43
1.43
0.37
0.34
0.39
0.38
0.40
0.67
0.72
0.69
0.78
0.68
Interest Coverage TTM
1.98
5.79
20.69
77.14
35.14
23.56
18.63
13.03
12.38
19.75
17.98
21.85
Debt Ratio
0.59
0.59
0.27
0.26
0.28
0.27
0.29
0.40
0.42
0.41
0.44
0.41
Efficiency & Turnover
Asset Turnover TTM
0.50
0.49
0.65
0.68
0.68
0.72
0.74
0.68
0.69
0.85
0.81
0.75
Days Sales Outstanding TTM
88.79
84.85
88.85
86.56
87.45
76.50
84.01
85.47
84.83
61.85
68.07
68.25
Receivables Turnover TTM
4.11
4.30
4.11
4.22
4.17
4.77
4.34
4.27
4.30
5.90
5.36
5.35
Per Share Metrics
Diluted EPS TTM
0.38
0.92
1.43
2.01
2.07
2.09
2.17
2.00
1.69
2.51
2.10
1.25
Free Cash Flow Per Share TTM
1.33
1.33
2.92
2.97
2.91
2.95
2.45
1.93
1.94
2.35
2.13
1.53
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
84.56%
86.63%
86.69%
86.04%
85.13%
84.42%
84.25%
83.17%
83.31%
85.31%
84.79%
85.11%
Operating Profit Margin TTM
7.03%
12.28%
17.21%
23.57%
24.86%
25.84%
27.00%
20.77%
19.70%
27.14%
24.90%
29.87%
Net Profit Margin TTM
3.97%
9.78%
16.37%
22.27%
23.15%
23.30%
23.57%
22.15%
19.15%
25.17%
21.39%
13.50%
Growth Metrics
Net Revenue Growth (1Y)
10.79%
3.21%
-5.25%
1.08%
-0.17%
-12.31%
-6.36%
-5.37%
3.14%
54.01%
49.61%
40.56%
Net Income Growth (1Y)
-81.02%
-56.70%
-34.16%
1.64%
20.69%
-18.81%
3.18%
55.24%
180.34%
-364.56%
-324.78%
-266.27%
EPS Growth (1Y)
-81.26%
-57.43%
-33.89%
0.59%
23.14%
-16.54%
3.70%
58.32%
176.93%
-359.99%
-321.43%
-263.95%
Valuation Metrics
P/E TTM
132.36
38.48
19.07
14.62
13.54
15.30
12.96
13.72
14.05
10.47
12.96
21.73
P/B TTM
4.84
3.36
2.53
2.86
2.91
3.57
3.25
3.54
3.16
3.62
3.83
3.44
P/S TTM
5.25
3.76
3.12
3.26
3.14
3.56
3.05
3.04
2.69
2.63
2.77
2.93
Market Cap
8.75B
5.88B
4.61B
4.95B
4.72B
5.40B
4.76B
4.57B
4.06B
4.55B
4.61B
4.67B
Enterprise Value
9.74B
7.04B
4.22B
4.34B
4.20B
5.00B
4.47B
4.47B
3.81B
4.42B
4.44B
4.31B
Calculated Values
Free Cash Flow TTM
221.61M
221.76M
480.29M
490.87M
479.84M
481.58M
405.64M
315.22M
327.15M
394.23M
353.31M
254.12M
Net Debt
991.58M
1.16B
-388.57M
-616.45M
-521.20M
-399.81M
-291.15M
-107.47M
-245.69M
-130.66M
-166.74M
-356.35M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-12Sale
Owner: Wright, Christopher I
Title: -
Shares: 2,000
Price/Share: $45.10
Value: $90,200.00
Shares Owned: 25,680
Relationship: Director
Ownership: Direct
2026-06-04Sale
Owner: Gaffin, David Joseph
Title: EVP, CLO, Alkermes, Inc.
Shares: 2,034
Price/Share: $43.05
Value: $87,563.70
Shares Owned: 229,524
Relationship: Officer
Ownership: Direct
2026-06-01Sale
Owner: Hopkinson, Craig C.
Title: EVP R&D, Chief Medical Officer
Shares: 9,000
Price/Share: $41.67
Value: $375,030.00
Shares Owned: 77,389
Relationship: Officer
Ownership: Direct
2026-05-29Sale
Owner: Parisi, Samuel Joseph
Title: VP, Finance (Interim PAO)
Shares: 16,217
Price/Share: $42.36
Value: $686,952.12
Shares Owned: 7,717
Relationship: Officer
Ownership: Direct
2026-05-04Sale
Owner: Gaffin, David Joseph
Title: EVP, CLO, Alkermes, Inc.
Shares: 2,034
Price/Share: $33.20
Value: $67,528.80
Shares Owned: 231,558
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
98.60%
Inst. Shares: 163,875,598
Shares Outstanding: 166,196,000
2025-12-31
102.06%
Inst. Shares: 168,092,900
Shares Outstanding: 164,703,000
2025-09-30
94.95%
Inst. Shares: 156,753,245
Shares Outstanding: 165,086,000
2025-06-30
94.24%
Inst. Shares: 155,457,863
Shares Outstanding: 164,959,000
2025-03-31
92.38%
Inst. Shares: 150,954,355
Shares Outstanding: 163,407,000

Alkermes plc. (ALKS) — SEC Financial Statements & Analysis

Alkermes plc. (ALKS) is a pharmaceutical preparations company. Alkermes plc. trades on Nasdaq as: ALKS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Alkermes plc. reported a 10.79% year-over-year revenue growth, a Gross Profit Margin of 84.56% (TTM), a Debt-to-Equity ratio of 1.43x, a Price-to-Sales (P/S) ratio of 5.25x (TTM), a Price-to-Book (P/B) ratio of 4.84x (TTM), at a market cap of $8.75B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
10.79%
Gross Profit Margin TTM
84.56%
Debt To Equity
1.43x
P/S TTM
5.25x
P/B TTM
4.84x
Market Cap
$8.75B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Alkermes plc. in?

Alkermes plc. (ALKS) operates in the Pharmaceutical Preparations industry.

What is ALKS's market cap?

Alkermes plc. (ALKS) has a market capitalization of $8.75B as of 2026-06-30.

What is ALKS's P/E ratio?

Alkermes plc. (ALKS)'s trailing twelve month P/E ratio is 132.36x as of 2026-06-30.

What exchange does ALKS trade on?

Alkermes plc. (ALKS) trades on the Nasdaq.

Wall Street's data.
Main Street's price.